首页> 外文期刊>Epilepsia Open >COX‐2/PGE2 axis regulates hippocampal BDNF/TrkB signaling via EP2 receptor after prolonged seizures
【24h】

COX‐2/PGE2 axis regulates hippocampal BDNF/TrkB signaling via EP2 receptor after prolonged seizures

机译:Cox-2 / PGE2轴通过EP2受体在长时间癫痫发作后通过EP2受体调节海马BDNF / TRKB信号传导

获取原文
           

摘要

Objective The objective of this study was to identify the signaling pathway that is immediately triggered by status epilepticus (SE) and in turn contributes to the excessive brain‐derived neurotrophic factor (BDNF)/tropomyosin‐related kinase receptor B (TrkB) signaling within the hippocampus. Methods We used quantitative PCR, enzyme‐linked immunosorbent assay, and Western blot analysis to examine gene expression at both mRNA and protein levels in the hippocampus following prolonged SE in mice and rats. Three classical animal models of SE were utilized in the present study to avoid any model‐ or species‐specific findings. Results We showed that both cyclooxygenase‐2 (COX‐2) and BDNF in the hippocampus were rapidly upregulated after SE onset; however, the induction of COX‐2 temporally preceded that of BDNF. Blocking COX‐2 activity by selective inhibitor SC‐58125 prevented BDNF elevation in the hippocampus following SE; prostaglandin E2 (PGE2), a major product of COX‐2 in the brain, was sufficient to stimulate hippocampal cells to secrete BDNF, suggesting that a PGE2 signaling pathway might be directly involved in hippocampal BDNF production. Inhibiting the Gαs‐coupled PGE2 receptor EP2 by our recently developed selective antagonist TG6‐10‐1 decreased the SE‐triggered phosphorylation of the cAMP response element‐binding protein (CREB) and activation of the BDNF/TrkB signaling in the hippocampus. Significance The molecular mechanisms whereby BDNF/TrkB signaling is upregulated in the hippocampus by SE largely remain unknown. Our findings suggest that COX‐2 via the PGE2/EP2 pathway regulates hippocampal BDNF/TrkB activity following prolonged seizures. EP2 inhibition by our bioavailable and brain‐permeable antagonists such as TG6‐10‐1 might therefore provide a novel strategy to suppress the abnormal TrkB activity, an event that can sufficiently trigger pathogenic processes within the brain including acquired epileptogenesis.
机译:目的本研究的目的是鉴定由状态癫痫(SE)立即引发的信号通路,反过来有助于在内部的过量的脑衍生的神经营养因子(BDNF)/ Tropomyosin相关激酶受体B(TRKB)信号传导海马。方法采用定量PCR,酶联免疫吸附试验和Western印迹分析,以检查在小鼠和大鼠延长Se后的海马MRNA和蛋白质水平的基因表达。在本研究中使用了三种古典动物模型,以避免任何型号或物种特异性发现。结果表明,在SE发作后,海马在海马中的环氧氧酶-2和BDNF均迅速上调;然而,COX-2的诱导在于BDNF的诱导。通过选择性抑制剂SC-58125阻断COX-2活性,防止在SE之后的海马中的BDNF升高;前列腺素E2(PGE2)是大脑中COX-2的主要产物,足以刺激海马细胞分泌BDNF,表明PGE2信号通路可能直接参与海马BDNF生产。我们最近开发的选择性拮抗剂TG6-10-1抑制Gαs偶联的PGE2受体EP2降低了CAMP响应元件结合蛋白(CREB)的SE-触发的磷酸化,并在海马中激活BDNF / TRKB信号传导。通过SE在海马中上调BDNF / TRKB信号传导的分子机制主要仍然未知。我们的研究结果表明,通过PGE2 / EP2途径的COX-2调节延长癫痫发作后的海马BDNF / TRKB活性。 EP2通过我们的生物可利用和脑渗透的拮抗剂如TG6-10-1的抑制可能提供一种抑制TRKB活性的新策略,这是一种可以充分引发脑内的脑内致病过程的事件,包括所得癫痫发作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号